Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02089672 · ClinicalTrials.gov registry record
RF Lesion Monitoring With 8mm IntellaTip MiFi XP
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 30
- Enrollment target
NCT02089672 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT02089672 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Abnormal heart rhythms or arrhythmias are often managed by a procedure in which a catheter is introduced into the heart. These catheters can then cauterize abnormally functioning portions of the heart muscle with the hope of returning the heart to a more effective rhythm. In the process of performing such a procedure, called a catheter ablation, an operator must be able to accurately sense electrical activity displayed on computer screens in different parts of the heart, provide sufficient localized energy to the abnormally behaving tissue (ideally without damaging uninvolved heart structures), and accurately reassess the electrical activity of the heart to ensure the spot in the heart has been cauterized. When sensing electrical activity of the heart, specialized catheters produce recordings on a computer screen known as electrograms (EGM). To produce this recording conventional catheters commonly use a positive and negative electrode, from which the difference between the two provides the EGM. The distance between the two electrodes varies from device to device. The greater the distance between them, the less accurate the measurement of local electrical activity becomes. This may result in poorly localized or excessive use of energy that could be damaging to normal heart structures or put the patient at risk for the return or development of additional arrhythmias. The IntellaTip MiFi catheter has been constructed with a specialized sensing tip that uses "microelectrodes" that are relatively close in proximity (\<1 mm apart) with the hope of improving the sensing capability of the device. This study will analyze the signals obtained from this FDA-approved catheter in people undergoing a catheter ablation procedure. The study will examine signals after the procedure is finished and will not prolong or differ the process from a standard ablation procedure. The goal of this study is to determine the ability of the microelectrodes to distinguish ablated, or cauterize
Interventions
- DEVICE Catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02089672
The ClinicalTrials.gov registry entry for NCT02089672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Catheter ablation is the first listed.
NCT02089672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02089672 about?
NCT02089672 is a clinical study titled "RF Lesion Monitoring With 8mm IntellaTip MiFi XP". Abnormal heart rhythms or arrhythmias are often managed by a procedure in which a catheter is introduced into the heart. These catheters can then cauterize abnormally functioning portions of the heart muscle with the hope of returning the heart to a more effective rhythm. In the process of performin...
What is the current status of trial NCT02089672?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-04. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02089672?
The interventions under investigation include: Catheter ablation (DEVICE).
Who is sponsoring clinical trial NCT02089672?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.